3 TSX Stocks That May Be Trading Below Their Estimated Value
As the Canadian market navigates a complex landscape marked by uncertainty around energy supply disruptions and economic surveys, investors are keenly observing how these factors might influence stock valuations. In such an environment, identifying stocks that may be trading below their estimated value can offer potential opportunities for those looking to balance growth with value in their portfolios.
|
Name |
Current Price |
Fair Value (Est) |
Discount (Est) |
|
Vitalhub (TSX:VHI) |
CA$8.07 |
CA$15.53 |
48.1% |
|
Montage Gold (TSX:MAU) |
CA$15.00 |
CA$25.70 |
41.6% |
|
Hemlo Mining (TSXV:HMMC) |
CA$6.35 |
CA$11.17 |
43.1% |
|
G Mining Ventures (TSX:GMIN) |
CA$50.95 |
CA$94.24 |
45.9% |
|
Ero Copper (TSX:ERO) |
CA$37.78 |
CA$65.81 |
42.6% |
|
EQB (TSX:EQB) |
CA$120.95 |
CA$214.80 |
43.7% |
|
Endeavour Mining (TSX:EDV) |
CA$86.02 |
CA$156.22 |
44.9% |
|
Constellation Software (TSX:CSU) |
CA$2651.50 |
CA$5291.16 |
49.9% |
|
Americas Gold and Silver (TSX:USA) |
CA$8.53 |
CA$15.21 |
43.9% |
|
ADF Group (TSX:DRX) |
CA$9.63 |
CA$16.67 |
42.2% |
Let’s review some notable picks from our screened stocks.
Overview: Knight Therapeutics Inc. is engaged in acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America with a market cap of CA$727.42 million.
Operations: The company’s revenue primarily comes from its pharmaceuticals segment, which generated CA$450.09 million.
Estimated Discount To Fair Value: 33.3%
Knight Therapeutics is trading at CA$7.43, significantly below its estimated future cash flow value of CA$11.14, suggesting it might be undervalued based on discounted cash flows. Despite a net loss of CA$5.37 million for 2025, the company forecasts revenue growth between CA$490 million and CA$510 million for 2026, outpacing the Canadian market average. The recent share buyback and product approvals in Latin America further bolster its financial position and growth potential.
Overview: Vermilion Energy Inc. is involved in petroleum and natural gas, focusing on acquiring, exploring, developing, and optimizing producing properties across North America, Europe, and Australia with a market cap of CA$2.51 billion.
Operations: The company generates CA$1.70 billion from its oil and gas exploration and production activities.
Estimated Discount To Fair Value: 41%
Vermilion Energy is trading at CA$16.78, well below its estimated future cash flow value of CA$28.46, highlighting potential undervaluation based on cash flows. Despite a net loss of CA$653.6 million in 2025, the company forecasts revenue growth exceeding the Canadian market average and anticipates becoming profitable within three years. Recent production outperformance and strategic share buybacks enhance its financial outlook, although high debt levels and significant insider selling warrant caution.
Overview: 5N Plus Inc. is a company that produces and sells specialty semiconductors and performance materials globally, with a market capitalization of CA$3.02 billion.
Operations: The company’s revenue is derived from two main segments: Performance Materials, contributing $105.66 million, and Specialty Semiconductors, accounting for $285.40 million.
Estimated Discount To Fair Value: 16.3%
5N Plus is trading at CA$33.41, below its estimated future cash flow value of CA$39.91, suggesting potential undervaluation based on cash flows. The company reported 2025 sales of US$391.06 million and net income of US$50.57 million, indicating strong financial performance with earnings growth outpacing the market forecast. However, significant insider selling in recent months and leadership changes, including a new CFO appointment, may introduce some uncertainty for investors to consider.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include TSX:GUD TSX:VET and TSX:VNP.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com